Malignancies

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

A Phase I Study of JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies.

9-ING-41 in Patients with Advanced Cancers

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143

Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy

Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Study of PWT33597 Mesylate in Subjects With Advanced Malignancies

Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies

Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)